© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Tracing the path of 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, most people in the scientific community first encountered it in the context of lung surfactant research. In the middle of the twentieth century, as neonatal medicine aimed to solve the puzzle of respiratory distress in newborns, DPPC showed up as a crucial piece. Some of the earliest landmark studies in pulmonary biology identified DPPC as the main driving molecule behind the surface tension-reducing capacity of lung surfactant, which keeps our alveoli open and our breathing smooth. It's no exaggeration to say that DPPC changed the outlook for premature infants and drove decades of research focused squarely on improving survival rates and long-term respiratory health.
DPPC carries a reputation for shaping the world of phospholipids. As a glycerophospholipid, it features two identical palmitic acid chains attached to a glycerol backbone, with a phosphocholine headgroup finishing the structure. You find it listed under several names in lab records—its extended IUPAC name, or sometimes as dipalmitoylphosphatidylcholine, or just "DPPC" among colleagues. In physical terms, DPPC forms lamellar phases readily and sits at a phase transition temperature near 41°C. Below this temperature, DPPC behaves as a gel, but as soon as you warm it, it shows a liquid crystalline nature, making it a backbone of countless membrane modeling experiments and synthetic lipid bilayer studies.
Researchers prize DPPC for its defined phase behavior and predictable fatty acid content. Both hydrocarbon chains in DPPC come from palmitic acid, a saturated 16-carbon fatty acid. This all-saturated setup delivers regular, organized packing in membranes, which helps scientists investigating order-disorder transitions or studying membrane protein activity. Most sources specify DPPC as a white powder or thin film at room temperature, often delivered with a purity exceeding 99% since contamination with peroxides or unsaturated fats can skew experimental outcomes. DPPC dissolves well in chloroform and methanol but not in water at room temperature; sonication or heating typically helps when you need to prepare aqueous dispersions.
Commercial DPPC usually comes from the controlled esterification of glycerol with palmitic acid derivatives in a lab setting, rather than direct extraction from biological tissues, sidestepping many of the variability issues seen with natural mixtures. Synthetic routes often use choline phosphate in the presence of activating reagents to couple the head group correctly. Careful purification follows, usually through chromatography based on charge and polarity differences, making sure the product meets stringent research standards. Some groups go for solid-phase approaches, while others use enzymatic synthesis for specialty projects like isotopic labeling or site-specific modification.
DPPC also acts as a flexible platform for chemical tweaking. Chemists sometimes attach fluorescent tags to study membrane dynamics, swap palmitate chains for other saturated or unsaturated acids, or introduce small charges or PEGylation for improving solubility. These modifications help answer tough questions about biophysical membrane properties, drug delivery, and microfluidic device coatings. Chemical reactions with DPPC generally target either the headgroup for labeling or the fatty acid tails for altering melting behavior or interactions with cholesterol and other lipids.
In my own notes and communications, I've seen DPPC labeled every which way: 1,2-dipalmitoylphosphatidylcholine, L-alpha-DPPC, and even just "PC(16:0/16:0)". Chemical catalogs and research reports cross-reference these synonyms, but among membrane scientists, "DPPC" usually suffices. This shorthand gets handed down in research group traditions, a detail that connects generations of biochemists tackling similar problems.
Working with DPPC doesn't demand complex safety protocols. It's a well-tolerated molecule, both in the bench environment and for most biological research, with none of the acutely hazardous characteristics seen in some organic solvents or reagents. That said, standard precautions apply: keep the powder off your skin, minimize inhalation risks, and store it dry and dark to avoid oxidation. For scientists, care focuses more on keeping the material uncontaminated by peroxides, as those introduce artifacts into sensitive measurements. Regular batch testing helps keep track of degradation or oxidation products, both to avoid surprises in experiments and to support reproducible results.
Application areas for DPPC stretch far and wide. It remains the gold standard for surfactant research—synthetic lung surfactant preparations rely on it, offering lifelines to preterm infants and providing template systems for studying respiratory biophysics. Biomedical engineers reach for DPPC in liposome construction, using its reproducible phase transition and tight packing to create stable drug delivery vehicles. In my own work, forming model membranes with DPPC laid the groundwork for studies of protein-lipid interactions and the effect of cholesterol on bilayer properties. Its phase transition point makes it a tool for studying temperature-dependent events in biological membranes and for simulating cell boundaries in artificial constructs.
Research on DPPC often means looking at what tweaks or additives can do for its basic properties. Labs pursue ultra-pure synthetic batches, new fluorinated or isotopically labeled forms for tracking through NMR or mass spectrometry, and blends with other phospholipids to mimic the diversity of natural membranes. DPPC also draws attention in nanomedicine for its use in targeted nanoparticles and as a stabilizer for imaging agents. Lately, investigating interactions between DPPC and environmental agents—pollutants, nanoparticles, or antimicrobial peptides—has become a hot topic, especially given the real-world exposure risk and the need to understand toxicity and biocompatibility.
So far, DPPC hasn't raised red flags in toxicity studies, one reason it's widely used in both animal models and clinical surfactants. Its natural occurrence in human tissue and metabolism via the lysophospholipid pathway support its safety profile. Still, questions pop up about what happens when modified DPPC molecules enter biological systems or persist in the environment after excretion in medical contexts. Lifelong accumulation doesn't seem to occur, but long-term ecological effects from modified lipid nanoparticles haven't been fully worked out. Keeping an eye on these questions is sensible, especially as lipid-based therapeutics, imaging agents, or nanocarriers get more common.
Looking ahead, DPPC could serve as a base for smarter, more tunable delivery platforms in medicine and as a platform for environmentally benign industrial applications. The broad interest in targeted therapies and diagnostic tools feeds ongoing innovation, with teams combining DPPC with responsive elements—light-, pH-, or enzyme-sensitive groups—to create “smart” liposomes that react on cue. In biophysical research, DPPC remains indispensable for its predictability, setting the standard for measuring subtle shifts in membrane order, permeability, and protein activity. Its future seems tied to progress in synthetic biology, biomedical engineering, and green chemistry, with new discoveries keeping this phospholipid in the spotlight for years to come.
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine—widely known as DPPC—turns up in labs everywhere for a good reason. This molecule belongs to the family of phospholipids and keeps showing up in research on cell membranes. DPPC’s molecular formula, C40H80NO8P, draws attention for its simplicity and its power. Its molecular weight clocks in at about 734.05 g/mol. These aren’t just sterile numbers. They guide how scientists build models of human lungs and study the way cells hold their shape.
Lung surfactant science leans hard on DPPC. Looking at a newborn baby’s first breath, this molecule steps up. DPPC has a knack for lowering the surface tension in the alveoli. Without enough of it, infants can land in trouble, facing conditions like infant respiratory distress syndrome. That story hits home for medical researchers, especially after seeing the improvements since the 1980s when doctors began giving synthetic surfactant therapies containing DPPC.
This molecule’s structure plays a crucial role, with its long palmitic acid chains (16 carbons each) providing a rigid backbone, and the phosphocholine headgroup pointing out toward water. Sitting at this border between water and air, DPPC shapes the very nature of biological boundaries in our bodies.
Not all DPPC comes from the same shelf. Purity and batch consistency matter, especially in research and drug development. Some sources extract it from egg or soy, but that leads to variability. Chemically synthesized DPPC mostly sidesteps this issue, giving the industry a more reliable product. In my lab days, no one wanted to run expensive experiments with cloudy results just because the lipid batch came from variable sources.
Academic priorities often meant pinching pennies, so the cheaper sources found their way into student projects. Sometimes, this led to frustrated undergrads confronting failed experiments. That experience stays with you. Investing in quality upfront spares a headache down the line.
One key solution: building partnerships between universities and reputable chemical suppliers. This might boost access to high-grade molecular building blocks like DPPC, supporting robust research outcomes for everyone involved. Funding agencies also stand to gain by backing these investments, recognizing that reproducibility often hangs on reliable starting materials.
Regulators can support this movement, updating guidance on raw material sourcing for pharmaceutical and biomedical products. Scientific journals might also push transparency, asking researchers to disclose supplier and batch information for all reagents, including phospholipids.
Beyond the hospital and the research bench, DPPC forms the backbone of liposomes for drug delivery. These tiny particles shuttle medicine into lungs, blood, and even inside cells. Some cancer therapies and vaccines take direct advantage of DPPC, a testament to the molecule’s versatility and utility. Clinical teams working with liposomal formulations benefit from a full understanding of how every atom in this molecule behaves under stress, temperature shifts, and mixing with other lipids.
Behind every calculation and every pipette tip, the numbers for DPPC’s formula and weight connect the math to better treatments. Appreciating those connections, researchers can keep shaping healthier futures.
Anyone who’s worked with DPPC, or dipalmitoylphosphatidylcholine, knows it isn’t your average chemical. As a phospholipid, DPPC won’t always cooperate with standard storage routines. I learned early on in my research days that shoving the vial on any open freezer shelf led to wasted product and weird results—DPPC doesn’t forgive sloppy storage.
Phospholipids hold together the structure of life’s membranes, but outside the body, they become fragile. Exposing DPPC to light, moisture, and oxygen speeds up hydrolysis and oxidation, two quick routes to spoiled stock. One published study from the Journal of Lipid Research highlights phospholipids breaking down after just a few months at room temperature, losing over 20% integrity. Failing to respect storage conditions marks the difference between clean data and experimental chaos.
Room temperature kills lipid standards. Science and experience both say DPPC belongs at -20°C or even colder at -80°C. Every time I left the freezer too long, the product started to degrade. Repeated cycles of thawing and freezing break DPPC down bit by bit; the literature backs up this caution. Flash freezing using liquid nitrogen and keeping it deep in a lab freezer preserves stability for years, according to product bulletins from major suppliers like Avanti Polar Lipids. The moment a vial spends too much time in a warm lab, breakdown accelerates. That error cost my lab a few hundred bucks and wasted weeks.
Desiccation adds another layer of protection—most reliable vendors package DPPC under argon or nitrogen in amber-glass bottles. Once opened, moisture from the air gets inside. From there, it’s a race against the clock. I always reseal opened bottles tightly, purge with nitrogen when possible, and keep a desiccant packet close by to mop up extra humidity. That habit saved more vials than I can count.
Lipids hate sunlight and UV exposure. Even a few afternoons under fluorescent lights can oxidize DPPC. I always store DPPC in dark, protective containers, away from bench lamps and sunny windows. If you want to stretch the shelf life, wrap the bottle in foil. Some colleagues shrug off this detail, but a faded, yellowed powder signals it's time to order fresh stock. Don’t let that happen to your experiment.
Research from the European Journal of Pharmaceutical Sciences points out that storing DPPC under vacuum or inert gas preserves its performance for months longer than samples sitting out in open air. If your lab doesn’t use nitrogen, consider at least flushing vials with argon before closing them up. Oxygen triggers peroxidation, changing properties in ways you can’t always spot until your results drift or your liposome prep fails.
Some labs have high-end automated freezers and oxygen-free glove boxes, but even with limited resources, you can extend DPPC’s shelf life. Always aliquot DPPC to avoid repeated freeze-thaw cycles. Keep stock in a dedicated box near the back of your frostiest freezer. Tight lids and backup labels help prevent confusion, since even a bit of water vapor can turn powdery lipid into sticky gunk.
Paying attention to these steps saves money and time. Even a gram of DPPC can cost several hundred dollars. More important than price, though, is reliability in your research. Nothing stings like realizing a failed run was avoidable with a bit of preparation.
Storing DPPC the right way isn’t just a best practice—it’s essential for reproducibility. Anyone planning experiments with this lipid will benefit from locking in these habits. Better storage means better science, and that’s something every lab should keep in mind.
DPPC, or dipalmitoylphosphatidylcholine, doesn’t get much attention outside the world of labs, but you’ll find it behind the scenes in projects that touch everything from healthcare to manufacturing. I remember my own first glimpse at lipid bilayers—silent, flat, but loaded with potential—and DPPC featured right at center stage. It’s more than another phospholipid; it shows up almost everywhere we study membranes.
DPPC draws so much attention in cell biology. Plenty of labs turn to DPPC as a backbone for model membranes thanks to its reliable structure and straightforward phase transition. Lipid bilayers built from DPPC have a knack for mimicking the real thing—something my old mentor used to call “cartoon simplicity with real-world rules.” By using DPPC, researchers tease apart how drugs wedge themselves between lipids, how pathogens grab hold of cells, and how molecules sneak past cell borders.
Patch together a DPPC-based membrane, then expose it to a new cancer drug, and you’ll see clear, repeatable ways the chemical behaves. There’s a reason journals fill up with DPPC in the methods sections for permeability and nanomedicine studies. It underpins work on liposomes, the little fat bubbles that deliver medication straight to tumors. The consistency you get with DPPC helps researchers compare trials and drive discoveries forward.
Drug delivery research leans on phospholipids to shield medicines through unfriendly environments—first stomach acid, then the onslaught of our immune system. DPPC stands out for the way it stores drugs and releases them at just the right pace. I’ve seen firsthand how liposomes built with DPPC carry chemotherapy agents to hard-to-reach places. Compared with synthetic lipids, DPPC handles temperature changes better, which matters for medicine that needs to last through shipping, storage, or simply sitting on the shelf.
Medical teams fighting respiratory distress in premature infants have another reason to thank DPPC. It makes up much of the surfactant used in treatments that keep fragile lungs from collapsing. Newborns with weak lungs risk breathing difficulties that sometimes require synthetic surfactant replacement, and DPPC brings the right balance of fluidity and stability for those delicate cell linings. The field keeps pushing for better blends, but DPPC stays front and center—if you check the ingredient lists in the major products, there it is.
Beyond medicine, DPPC turns up in less obvious places. Some food technologists use it to keep ingredients from separating, while cosmetic chemists blend it into skincare formulas looking for that “skin-like” touch. DPPC helps creams glide and feel natural, acting a lot like what’s already in our own cell membranes. The demand for gentle, biocompatible emulsifiers gives DPPC a natural path into new consumer products.
The reliance on DPPC sparks bigger questions in research and industry. Sourcing high-purity, cost-effective DPPC challenges suppliers and buyers, especially as more researchers look for sustainable or plant-based alternatives to animal-derived materials. Regular audits, batch testing, and greater transparency about sourcing could help address these worries. Supporting labs that research alternative lipid sources—such as using microbes or engineered yeast—can grow more dependable supply chains and reduce ethical concerns.
DPPC shows that even a single molecule can play an outsized role across science and industry. Its influence stretches from the narrow world of the lab bench to the broader arenas of medicine and manufacturing—a reminder that progress depends as much on humble building blocks as it does on big ideas.
DPPC, or dipalmitoylphosphatidylcholine, has become a staple in many research labs exploring liposome technology and membrane dynamics. Its structure—two palmitic acid chains attached to a phosphatidylcholine head—means it shares properties with natural cell membranes. Many turn to DPPC because of its well-documented phase behavior and stability. Unlike some other phospholipids, DPPC transitions cleanly between gel and liquid crystalline phases near 41°C, making it a reliable benchmark for thermal studies.
In early membrane experiments, choosing a model system that avoided surprises mattered most. DPPC fit the bill thanks to its predictable melting temperature. Researchers like me have watched how small tweaks—changing acyl chain length or headgroup—can send melting points up or down. But DPPC’s melting point lands in a useful range, especially for studies mimicking physiological conditions or testing drug delivery systems. The reproducibility saves time and resources, leaving room to focus on actual discoveries rather than troubleshooting batch inconsistencies.
Studies show that DPPC liposomes hold strong in the face of common buffer compositions and moderate mixing. Experiences in the lab prove that DPPC vesicles rarely break or fuse out of turn unless exposed to temperatures well above 41°C or exposed to disruptive solvents. That helps when loading them with substances or tracking them in simulated biological settings.
DPPC’s strengths in the lab don’t mean it solves every challenge. One big hurdle stands out: DPPC is fully saturated, meaning its fatty acid tails lack double bonds. This gives rigidity. Some biological membranes, especially those in mammals, include plenty of unsaturated lipids, which boost fluidity and influence protein function. Experiments using only DPPC may oversimplify membrane landscapes, missing phenomena tied to natural complexity.
My colleagues often remark on this after trying to study membrane proteins or drug–membrane interactions. Some drugs behave differently in DPPC liposomes compared to those with unsaturated lipids. For example, insertion and diffusion rates for peptides and small molecules shift in less rigid environments. This mismatch can lead to discrepancies between lab results and real biological systems.
Factoring in natural diversity matters for translational science. Many teams address DPPC’s limits by mixing it with unsaturated lipids like DOPC or cholesterol, mimicking the physical properties of natural membranes. These blends help uncover insights into raft domains, membrane permeability, and protein mobility. Even classic studies rely on such blends to parse out phenomena impossible to spot with DPPC alone. Adding cholesterol, for example, produces tighter packing, mirroring animal cell membranes more closely.
Switching up lipid compositions has helped researchers confirm results from DPPC-only systems and reveal new layers of complexity. Over the years, cross-checking findings in mixed lipid systems exposed unexpected behaviors of peptides, drugs, and channels that never showed up in pure DPPC experiments.
Quality matters deeply. Trace oxidation or impurities in DPPC can tilt experimental outcomes, so sourcing from reputable vendors and checking quality certificates remains a basic step. Following lab safety protocols protects both researchers and research integrity, especially given the growing push for reproducibility and transparency in science. Recent calls for open data and responsible sourcing underscore the value of respecting these precautions.
Strong foundation or not, it makes sense to remember that models like DPPC aren’t stand-ins for living membranes. They spark ideas and streamline protocols, but the next leap in membrane research relies on thoughtful pairing of model systems with clear experimental aims.
DPPC, or 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, pops up in labs as a model phospholipid. Researchers rely on its structure for cell membrane studies, lung surfactant research, and in drug delivery work, especially liposome formulation. But not all DPPC is created equal, and that difference comes from purity and form—two details that decide how experiments play out.
DPPC's magic depends on purity. The top-tier material will hit 99% or more on the purity scale, with suppliers using methods like HPLC or NMR for confirmation. Any impure batch can set off headaches, introducing unknowns that cloud results and muddy data. Labs working on therapeutics, for example, need absolute confidence in every lipid molecule; drug approvals ride on that trust.
Chemical impurities in DPPC—oxidized lipids, short-chain byproducts, even leftover solvents—can trigger immune responses or cause membrane instability. I once watched data unravel simply because a batch didn’t meet the claimed specs. Bad purity forced the team through wasted weeks troubleshooting instead of moving ahead. After that, the focus switched to vendors with clear testing and batch records, and consistency improved overnight.
DPPC doesn’t travel solo in just one look. Find it as a fine white powder, lyophilized cake, or in chloroform solution. Each form brings quirks that affect storage and usage. Powders bring a good shelf life, but attract moisture like a magnet if not kept up tight. Solutions let scientists skip some prep but cut down on storage time and raise costs. Lyophilized versions lower the risk of water and oxidation but call for careful handling to prevent contamination during rehydration.
I remember early days prepping a liposome batch. Using a poorly sealed powder led to strange vesicle sizes. After moving to air-tight ampules, the repeatability came back. It’s small tweaks in handling that highlight how tightly form and quality link together.
Storing DPPC takes more than just tossing it on the shelf. Most suppliers recommend -20°C, away from light and humidity, no matter the form. Lipids oxidize—and once that process starts, redemption doesn’t come easy. The tiniest crease in quality control can spoil months of work downstream.
Scientists should stay in touch with vendors—keep questions flowing about lot testing, audit trails, or how issues get managed. No step in research needs “good enough” material. Forums and peer support groups help flag problematic sources early on, and sometimes a simple supplier switch improves results. Investing in handheld analytical tools, such as small NMR or FTIR devices, can offer batch quality spot checks in-house for those working at scale.
At the end of the pipeline, purity and form write the story for every DPPC-driven project. Getting it right means better science, stronger therapies, and results you can stand up and defend.
| Names | |
| Preferred IUPAC name | 2,3-bis(hexadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate |
| Other names |
Dipalmitoylphosphatidylcholine Dipalmitoyllecithin L-alpha-Dipalmitoylphosphatidylcholine 1,2-Dipalmitoylphosphatidylcholine 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine DPPC |
| Pronunciation | /ˌdaɪ.pælˈmɪ.tɔɪl sn ɡlaɪˈsɪə.roʊ ˈfriː fɒs.foʊˌkoʊ.lin/ |
| Identifiers | |
| CAS Number | 063198-41-7 |
| Beilstein Reference | 1711351 |
| ChEBI | CHEBI:73163 |
| ChEMBL | CHEMBL1237098 |
| ChemSpider | 21466972 |
| DrugBank | DB11129 |
| ECHA InfoCard | 18e045f7-6fba-42b1-9419-8eae8041c3d7 |
| EC Number | 3.1.1.4 |
| Gmelin Reference | 70256 |
| KEGG | C04230 |
| MeSH | D050556 |
| PubChem CID | 467462 |
| RTECS number | OYP6546Z96 |
| UNII | UJ9685R58O |
| UN number | Not regulated |
| Properties | |
| Chemical formula | C40H80NO8P |
| Molar mass | 734.05 g/mol |
| Appearance | White powder |
| Odor | Odorless |
| Density | 1 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | logP = 7.16 |
| Vapor pressure | Negligible |
| Acidity (pKa) | pKa ≈ 1.9 (phosphate), ≈ 13.0 (choline) |
| Basicity (pKb) | pKb ≈ 5.8 |
| Magnetic susceptibility (χ) | -75.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.478 |
| Viscosity | 10 mPa·s (at 25 °C) |
| Dipole moment | 10.15 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 1476.6 J/mol·K |
| Std enthalpy of formation (ΔfH⦵298) | -1643.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -16150 kJ/mol |
| Pharmacology | |
| ATC code | A06AA01 |
| Hazards | |
| Main hazards | Not a hazardous substance or mixture. |
| GHS labelling | Not a hazardous substance or mixture. |
| Pictograms | GHS07 |
| Hazard statements | Not a hazardous substance or mixture. |
| Precautionary statements | Precautionary statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Flash point | > 250°C |
| Explosive limits | Non-explosive |
| LD50 (median dose) | LD50 (median dose): >2,000 mg/kg (rat, oral) |
| NIOSH | SDC6898000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 100 mg |
| Related compounds | |
| Related compounds |
1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) Phosphatidylethanolamine Phosphatidylserine Sphingomyelin |
